Harnessing the therapeutic potential of FKBPL in Parkinson’s Disease
Parkinson’s Disease (PD) is the second most frequent, degenerative neurological condition affecting up to ten million worldwide and occurs through loss of dopamine-producing neurons. PD etiology/pathogenesis remain incompletely understood, however, mitochondrial dysfunction, protein aggregation and neuroinflammation play a role in PD development.